Company / Inventory
BIOCRYST PHARMACEUTICALS INC Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$5.4M
FY2025
5-year range
$5.4M / $28.7M
FY2021-FY2025
Trend
-33.3%
vs FY2024
Sector context
#95 of 105
Health Care
What the data says
Among 105 Health Care companies, BIOCRYST PHARMACEUTICALS INC is in the bottom 10% for inventory. Inventory has fluctuated over the past 9 years, ranging from $0 in FY2019 to $29M in FY2023.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of -5.2%.
Declined from $29M to $5M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -41.9%
- 5-Year CAGR
- -5.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 105This company $5.4M Sector average $885.3M
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -5.2%, indicating a declining trend.
- In FY2025, inventory decreased 33.3% year-over-year.
- Ranks #95 out of 105 companies in the Health Care sector.
- Peak inventory was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.4M | -33.3% |
| FY2024 | $8.1M | -71.8% |
| FY2023 | $28.7M | +4.2% |
| FY2022 | $27.5M | +74.4% |
| FY2021 | $15.8M | +124.3% |
| FY2020 | $7.0M | - |
| FY2019 | $0 | -100.0% |
| FY2018 | $1.6M | - |
| FY2017 | - | - |
| FY2016 | $500.0K | -69.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026